| Name: | Eletriptan Impurity L |
| Catalogue No. | VL990007 |
| CAS No. | 1217641-89-8 |
| Molecular Formula | C22H26N2O3S |
| Molecular Weight | 398.52 |
| Status | In-stock |
| IUPAC Name | 3-[[(2R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole N-Oxide |
| Synonyms | Eletriptan N-Oxide |
| Description | "Eletriptan Impurity L or Eletriptan N-Oxide (CAS No.1217641-89-8) or 3-[[(2R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole N-Oxide . Eletriptan is an orally administered, lipophilic, highly selective serotonin 5-HT receptor agonist. It is used in the treatment of moderate to severe migraine in adults." |
| References | "Goadsby, P. J., et al. “Eletriptan in Acute Migraine: A Double-Blind, Placebo-Controlled Comparison to Sumatriptan.” Neurology, vol. 54, no. 1, Jan. 2000, pp. 156–56, https://doi.org/10.1212/wnl.54.1.156. McCormack, Paul L., and Gillian M. Keating. “Eletriptan.” Drugs, vol. 66, no. 8, 2006, pp. 1129–49, https://doi.org/10.2165/00003495-200666080-00010. " |
